Search results for "Coronavirus"


 
Results 41 - 50 of about 273 for "Coronavirus".
Sort by: Relevance | Newest | Oldest

Research on CPAP, HFNO, IVIG, and lung transplants for COVID-19

One study found that continuous positive airway pressure (CPAP) outperformed conventional oxygen, but high-flow nasal oxygen (HFNO) did not. Another found no benefit from hyperimmune IV immunoglobulin (IVIG) in hospitalized patients. Two analyses showed good outcomes from lung transplants in COVID-19 patients.
https://acphospitalist.acponline.org/archives/2022/02/02/free/research-on-cpap-hfno-ivig-and-lung-transplants.htm
2 Feb 2022

Adding P2Y12 inhibitor to heparin offered no benefit in non-critically ill COVID-19 inpatients

An open-label randomized trial at 60 hospitals in four countries found no increase in organ support-free days in patients who received a therapeutic dose of heparin plus a P2Y12 inhibitor versus heparin alone.
https://acphospitalist.acponline.org/archives/2022/01/19/free/adding-P2Y12-inhibitor-to-heparin-offered-no-benefit.htm
19 Jan 2022

How COVID-19 changed end-of-life care

Hospitalists have had to find new strategies during the pandemic in order to provide optimal care, including company and comfort, to dying inpatients and their families.
https://acphospitalist.acponline.org/archives/2022/01/12/free/how-covid-19-changed-end-of-life-care.htm
12 Jan 2022

NIH guidelines on anticoagulation in COVID-19; research on statin use, omicron variant

The NIH updated its guidelines to address anticoagulation in COVID-19 inpatients, treatment with atorvastatin did not appear to improve outcomes in the ICU, and several studies looked at characteristics of omicron.
https://acphospitalist.acponline.org/archives/2022/01/12/free/nih-guidelines-on-anticoagulation-research-on-statins-and-COVID-19.htm
12 Jan 2022

COVID-19 guideline update from NIH, postdischarge anticoagulation, remdesivir effects

The latest news on inpatient COVID-19 care includes some changes to the NIH guidelines for COVID-19 treatment, as well as studies showing that rivaroxaban after discharge reduced clots and remdesivir helped inpatients on no or low-flow oxygen but not those who were sicker.
https://acphospitalist.acponline.org/weekly/archives/2021/12/22/1.htm
22 Dec 2021

Convalescent plasma did not facilitate recovery in COVID-19 inpatients, trial finds

There was a suggestion of benefit from plasma in patients treated earlier in the pandemic, before remdesivir and corticosteroids became the standard of care, according to exploratory analyses of this multicenter study.
https://acphospitalist.acponline.org/weekly/archives/2021/12/15/2.htm
15 Dec 2021

Early high-flow oxygen reduced need for mechanical ventilation, sped recovery

About a third of hypoxemic patients with severe COVID-19 who were randomized to high-flow nasal oxygen in the ED or ICU were eventually intubated, compared to 51% of those who received conventional oxygen, a trial in Columbia found.
https://acphospitalist.acponline.org/weekly/archives/2021/12/08/1.htm
8 Dec 2021

Aspirin for COVID-19 inpatients didn't reduce mortality, trial finds

New data from the RECOVERY trial found a slight reduction in clots but an increase in bleeding and no difference in 28-day mortality in patients randomized to daily aspirin during hospitalization compared to those receiving usual care.
https://acphospitalist.acponline.org/weekly/archives/2021/11/24/2.htm
24 Nov 2021

Monitoring outpatients by text appeared to reduce mortality from COVID-19

Patients with SARS-CoV-2 who received twice-daily, automated text message check-ins with an option to report worsening symptoms at any time had lower 30- and 60-day mortality than outpatients receiving usual care, a retrospective study found.
https://acphospitalist.acponline.org/weekly/archives/2021/11/17/4.htm
17 Nov 2021

Latest studies look at pneumonia scores and stroke rates in inpatients with COVID-19

The PSI and CURB-65 work in patients with pneumonia from SARS-CoV-2, one study found, while another estimated stroke rates in COVID-19 inpatients. Research on breakthrough infections showed that full vaccination provided more protection than previous infection, among other findings.
https://acphospitalist.acponline.org/weekly/archives/2021/11/10/1.htm
10 Nov 2021

Result Page: Prev   1   2   3   4   5   6   7   8   9   10   Next